| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.591 | 21.825 | 26.230 | 36.768 | 41.812 | 42.913 | 62.590 | 51.156 | 47.666 | 46.855 |
| Total Income - EUR | 3.591 | 21.825 | 26.230 | 36.770 | 41.813 | 42.960 | 62.592 | 51.162 | 47.672 | 46.856 |
| Total Expenses - EUR | 1.995 | 7.105 | 13.230 | 12.540 | 14.247 | 15.261 | 14.665 | 17.366 | 16.297 | 20.285 |
| Gross Profit/Loss - EUR | 1.596 | 14.720 | 12.999 | 24.230 | 27.566 | 27.699 | 47.926 | 33.796 | 31.375 | 26.571 |
| Net Profit/Loss - EUR | 1.488 | 14.510 | 12.666 | 23.881 | 27.129 | 27.270 | 47.300 | 33.285 | 30.898 | 23.170 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pufmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 8.673 | 6.186 | 4.551 | 5.228 | 2.318 | 1.680 | 785 |
| Current Assets | 2.700 | 17.992 | 27.638 | 21.183 | 33.258 | 61.444 | 64.652 | 32.197 | 35.539 | 23.580 |
| Inventories | 697 | 690 | 679 | 0 | 0 | 0 | 37 | 0 | 0 | 0 |
| Receivables | 0 | 7.499 | 18.984 | 5.912 | 3.895 | 4.007 | 4.987 | 4.575 | 5.543 | 1.401 |
| Cash | 2.002 | 9.802 | 7.976 | 15.271 | 29.363 | 57.437 | 59.628 | 27.623 | 29.996 | 22.179 |
| Shareholders Funds | 173 | 14.681 | 27.099 | 24.695 | 38.702 | 65.238 | 69.159 | 33.329 | 36.207 | 23.214 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.527 | 3.311 | 539 | 5.164 | 744 | 759 | 721 | 1.186 | 1.015 | 1.935 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pufmed Srl